72 related articles for article (PubMed ID: 19482098)
1. Alpha-fetoprotein for hepatocellular carcinoma diagnosis: the demise of a brilliant star.
Forner A; Reig M; Bruix J
Gastroenterology; 2009 Jul; 137(1):26-9. PubMed ID: 19482098
[No Abstract] [Full Text] [Related]
2. Circulating tumor-derived DNA is shorter than somatic DNA in plasma.
Mouliere F; Rosenfeld N
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3178-9. PubMed ID: 25733911
[No Abstract] [Full Text] [Related]
3. E2F1-mediated Up-regulation of NCAPG Promotes Hepatocellular Carcinoma Development by Inhibiting Pyroptosis.
Xiao C; Gong J; Jie Y; Liang W; Tai Y; Qin W; Lu T; Chong Y; Hei Z; Hu B; Zhang Q
J Clin Transl Hepatol; 2024 Jan; 12(1):25-35. PubMed ID: 38250463
[TBL] [Abstract][Full Text] [Related]
4. Circulating Extracellular Vesicle-Derived microRNAs as Novel Diagnostic and Prognostic Biomarkers for Non-Viral-Related Hepatocellular Carcinoma.
Boonkaew B; Satthawiwat N; Pinjaroen N; Chuaypen N; Tangkijvanich P
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003232
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma.
Kohansal-Nodehi M; Swiatek-de Lange M; Kroeniger K; Rolny V; Tabarés G; Piratvisuth T; Tanwandee T; Thongsawat S; Sukeepaisarnjaroen W; Esteban JI; Bes M; Köhler B; Chan HL; Busskamp H
Front Oncol; 2023; 13():1213898. PubMed ID: 37920152
[TBL] [Abstract][Full Text] [Related]
6. Demographic, clinical and aetiological characteristics of patients with hepatocellular carcinoma followed between 2012 and 2017 at University Hospital Joseph Raseta Befelatanana, Antananarivo, Madagascar.
Rakotozafindrabe ALR; Razafindrazoto CI; Laingonirina DHH; Ralideramanambina TB; Ralaizanaka BM; Maherison S; Rakotomalala JA; Randriamifidy NH; Rasolonjatovo AS; Rabenjanahary TH; Razafimahefa SH; Ramanampamonjy RM
Ecancermedicalscience; 2022; 16():1466. PubMed ID: 36819823
[TBL] [Abstract][Full Text] [Related]
7. The Performance of Serum Alpha-Fetoprotein for Detecting Early-Stage Hepatocellular Carcinoma Is Influenced by Antiviral Therapy and Serum Aspartate Aminotransferase: A Study in a Large Cohort of Hepatitis B Virus-Infected Patients.
Qian X; Liu Y; Wu F; Zhang S; Gong J; Nan Y; Hu B; Chen J; Zhao J; Chen X; Pan W; Dang S; Lu F
Viruses; 2022 Jul; 14(8):. PubMed ID: 36016291
[TBL] [Abstract][Full Text] [Related]
8. Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma.
Johnson P; Zhou Q; Dao DY; Lo YMD
Nat Rev Gastroenterol Hepatol; 2022 Oct; 19(10):670-681. PubMed ID: 35676420
[TBL] [Abstract][Full Text] [Related]
9. A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody-antigen system.
Wu J; Wang P; Han Z; Li T; Yi C; Qiu C; Yang Q; Sun G; Dai L; Shi J; Wang K; Ye H
Cancer Sci; 2022 Feb; 113(2):411-422. PubMed ID: 34821436
[TBL] [Abstract][Full Text] [Related]
10. Identification of BHLHE40 expression in peripheral blood mononuclear cells as a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma.
Kunadirek P; Ariyachet C; Sriphoosanaphan S; Pinjaroen N; Sirichindakul P; Nookaew I; Chuaypen N; Tangkijvanich P
Sci Rep; 2021 May; 11(1):11201. PubMed ID: 34045534
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumour DNA methylation in hepatocellular carcinoma diagnosis using digital droplet PCR.
Wang J; Yang L; Diao Y; Liu J; Li J; Li R; Zheng L; Zhang K; Ma Y; Hao X
J Int Med Res; 2021 Mar; 49(3):300060521992962. PubMed ID: 33750234
[TBL] [Abstract][Full Text] [Related]
12. Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml).
Liang L; Wang MD; Zhang YM; Zhang WG; Zhang CW; Lau WY; Shen F; Pawlik TM; Huang DS; Yang T
J Hepatocell Carcinoma; 2021; 8():103-118. PubMed ID: 33748017
[TBL] [Abstract][Full Text] [Related]
13. High pre-treatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinoma.
Czauderna C; Schmidtmann I; Koch S; Pilz L; Heinrich S; Otto G; Mittler J; Lang H; Kloeckner R; Düber C; Sprinzl MF; Wörns MA; Galle PR; Marquardt JU; Weinmann A
United European Gastroenterol J; 2020 Nov; 9(3):2050640620972611. PubMed ID: 33226301
[TBL] [Abstract][Full Text] [Related]
14. Reappraisal of the diagnostic value of alpha-fetoprotein for surveillance of HBV-related hepatocellular carcinoma in the era of antiviral therapy.
Qian X; Liu S; Long H; Zhang S; Yan X; Yao M; Zhou J; Gong J; Wang J; Wen X; Zhou T; Zhai X; Xu Q; Zhang T; Chen X; Hu G; Wang J; Gao Z; Nan Y; Chen J; Hu B; Zhao J; Lu F
J Viral Hepat; 2021 Jan; 28(1):20-29. PubMed ID: 32852885
[TBL] [Abstract][Full Text] [Related]
15. Serological Biomarkers for Early Detection of Hepatocellular Carcinoma: A Focus on Autoantibodies against Tumor-Associated Antigens Encoded by Cancer Driver Genes.
Wang K; Li M; Qin J; Sun G; Dai L; Wang P; Ye H; Shi J; Cheng L; Yang Q; Qiu C; Jiang D; Wang X; Zhang J
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32443439
[TBL] [Abstract][Full Text] [Related]
16. Signification of Serum Alpha-Fetoprotein Levels in Cases of Compensated Cirrhosis and Hepatitis C Virus without Hepatocellular Carcinoma.
Manuc D; Preda CM; Sandra I; Baicus C; Cerban R; Constantinescu I; Olteanu AO; Ciora CA; Manuc T; Chiriac DE; Chifulescu AE; Diculescu M; Tieranu C; Negreanu L; Oprea-Calin G; Manuc M
J Med Life; 2020; 13(1):68-74. PubMed ID: 32341704
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P
PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203
[TBL] [Abstract][Full Text] [Related]
18. Detect or not to detect very early stage hepatocellular carcinoma? The western perspective.
Yang JD
Clin Mol Hepatol; 2019 Dec; 25(4):335-343. PubMed ID: 30924328
[TBL] [Abstract][Full Text] [Related]
19. Familial hepatocellular carcinoma: 'A model for studying preventive and therapeutic measures'.
Weledji EP
Ann Med Surg (Lond); 2018 Nov; 35():129-132. PubMed ID: 30305894
[TBL] [Abstract][Full Text] [Related]
20. miR-342-3p suppresses hepatocellular carcinoma proliferation through inhibition of IGF-1R-mediated Warburg effect.
Liu W; Kang L; Han J; Wang Y; Shen C; Yan Z; Tai Y; Zhao C
Onco Targets Ther; 2018; 11():1643-1653. PubMed ID: 29615839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
